Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels.
about
Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profileEchinocandin pharmacodynamics: review and clinical implications.Effects of host response and antifungal therapy on serum and BAL levels of galactomannan and (1→3)-β-D-glucan in experimental invasive pulmonary aspergillosis.In vitro activities of echinocandins against Candida krusei determined by three methods: MIC and minimal fungicidal concentration measurements and time-kill studies.
P2860
Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Activity of anidulafungin in a ...... um (1,3)-beta-D-glucan levels.
@en
Activity of anidulafungin in a ...... um (1,3)-beta-D-glucan levels.
@nl
type
label
Activity of anidulafungin in a ...... um (1,3)-beta-D-glucan levels.
@en
Activity of anidulafungin in a ...... um (1,3)-beta-D-glucan levels.
@nl
prefLabel
Activity of anidulafungin in a ...... um (1,3)-beta-D-glucan levels.
@en
Activity of anidulafungin in a ...... um (1,3)-beta-D-glucan levels.
@nl
P2093
P2860
P356
P1476
Activity of anidulafungin in a ...... um (1,3)-beta-D-glucan levels.
@en
P2093
Daniel J Sheehan
Jose Rodriguez
Luis Ostrosky-Zeichner
Victor L Paetznick
P2860
P304
P356
10.1128/AAC.00955-08
P407
P577
2009-01-12T00:00:00Z